Early Surgery versus Conventional Treatment for Infective Endocarditis
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The timing and indications for surgical intervention to prevent systemic embolism in infective endocarditis remain controversial. We conducted a trial to compare clinical outcomes of early surgery and conventional treatment in patients with infective endocarditis. METHODS: We randomly assigned patients with left-sided infective endocarditis, severe valve disease, and large vegetations to early surgery (37 patients) or conventional treatment (39). The primary end point was a composite of in-hospital death and embolic events that occurred within 6 weeks after randomization. RESULTS: All the patients assigned to the early-surgery group underwent valve surgery within 48 hours after randomization, whereas 30 patients (77%) in the conventional-treatment group underwent surgery during the initial hospitalization (27 patients) or during follow-up (3). The primary end point occurred in 1 patient (3%) in the early-surgery group as compared with 9 (23%) in the conventional-treatment group (hazard ratio, 0.10; 95% confidence interval [CI], 0.01 to 0.82; P=0.03). There was no significant difference in all-cause mortality at 6 months in the early-surgery and conventional-treatment groups (3% and 5%, respectively; hazard ratio, 0.51; 95% CI, 0.05 to 5.66; P=0.59). The rate of the composite end point of death from any cause, embolic events, or recurrence of infective endocarditis at 6 months was 3% in the early-surgery group and 28% in the conventional-treatment group (hazard ratio, 0.08; 95% CI, 0.01 to 0.65; P=0.02). CONCLUSIONS: As compared with conventional treatment, early surgery in patients with infective endocarditis and large vegetations significantly reduced the composite end point of death from any cause and embolic events by effectively decreasing the risk of systemic embolism. (EASE ClinicalTrials.gov number, NCT00750373.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several rigorously conducted observational studies 11,[14][15][16] and a randomized, controlled trial 17 have examined the impact and timing of valve surgery in IE management.”
In the citing paper
“Although the authors 17 report a reduction in the composite outcome of in-hospital deaths and embolic events with early surgery (3% versus 23%), the differences between the 2 groups were driven by a significant decrease in embolic events with early surgery.”
In the citing paper
“In addition, patients in this trial were young and had limited comorbidity based on a EuroSCORE, a calculated risk of surgical mortality (http://www.euroscore.org), a low prevalence of S aureus IE, and lower mortality compared with most contemporary patient cohorts.”
In the citing paper
“Although valve replacement surgery has served as an important option in the management of individual IE cases, only 1 small, randomized trial 17 has been performed to date to examine the role of valve surgery in the management of IE.”
In the citing paper
“In this trial, 76 patients with left-sided NVE, severe valve regurgitation without heart failure, and vegetations >10 mm were assigned to early surgery within 48 hours or to conventional treatment.”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176857 · Cited by 8,495
Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G., Ryan, T., Bashore, T., & Corey, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313753 · Cited by 4,027
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.021 · Cited by 1,702
Infective Endocarditis in Adults
Mylonakis, E., & Calderwood, S. B. (2001) · New England Journal of Medicine · doi:10.1056/nejmra010082 · Cited by 1,324
Moreillon, P., & Que, Y.-A. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15266-x · Cited by 861
Thuny, F., Disalvo, G., Belliard, O., Avierinos, J.-F., Pergola, V., Rosenberg, V., Casalta, J.-P., Gouvernet, J., Derumeaux, G., Iarussi, D., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.493155 · Cited by 703
Infective endocarditis in Europe: lessons from the Euro heart survey
Tornos, P., Iung, B., Permanyer-Miralda, G., Baron, G., Delahaye, F., Gohlke-Bärwolf, C., Butchart, E. G., Ravaud, P., & Vahanian, A. (2005) · Heart · doi:10.1136/hrt.2003.032128 · Cited by 476
Emboli in Infective Endocarditis: The Prognostic Value of Echocardiography
Steckelberg, J. M., Murphy, J. G., Ballard, D., Bailey, K., Tajik, A. J., Taliercio, C. P., Giuliani, E. R., & Wilson, W. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-8-635 · Cited by 411
Cited by
Items 901–920 of 920
Rani, N. H. A., Mohamed, A. B., Isa, Z. M., Kadiman, S., & Kamarudin, T. A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15166281
Christov, G., Dixon, G. L. J., & Kostolny, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11851-7.00067-7
Bratosin, F., DeSanctis, J. T., & Simeunovic, G. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15176669
“…to emphasize surgery as the standard approach for left-sided IE when there is heart failure, uncontrolled infection, or a strong embolic prevention indication, while randomized evidence, such as early surgery for large vegetations, supports embolic-risk reduction in selected patients [56,57].”
Turaev, F., Turaev, Z., & Ismailov, S. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1017582
Bravo, C. F. (2026) · Research Square · doi:10.21203/rs.3.rs-10855464/v1
Hajji, A., Ali, D., Bechri, I., Shimi, A., & Khatouf, M. (2026) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2026.31.2.2242
Radu, A. M., Talposi, I. F., Țoțoiu, R. E., Berbecaru, R., Dobrin, A., Melinte, V., Văcăroiu, C. M., Holban, T. S., Popa, M. C., Călinoiu, A. L., et al. (2026) · Antibiotics · doi:10.3390/antibiotics15100997
“Early surgery reduced the composite endpoint of in-hospital death or embolic events, principally through fewer embolic events, without a statistically significant difference in all-cause mortality at 6 months [24].”
Isquemia arterial aguda de grandes vasos: forma rara de apresentação de endocardite em doente jovem
Ferreira, B., Ribeiro, S., Rocha, S., Almeida, F., & Correia, J. (2013) · Revista Portuguesa de Doenças Infecciosas (RPDI) · doi:10.65332/rpdi.v9.244
Nomogram-based prediction of in-hospital mortality and embolic events in infective endocarditis
Liu, C., Fan, J., 余炳波, Li, W., Wang, S., Zhao, B., Luo, S., Jiang, S., & Xu, X. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1923055
“Because real-world surgical decisions are heavily driven by clinicians’ subjective perceptions of operative tolerance (Kang et al., 2012), incorporating surgery would introduce a profound treatment-indication bias.”
Motawea, K. R., Blackledge, M., Al-Sheikh, A. M., El-Diasty, M. M., Elgudin, Y. E., Sabik, J. F., & Abu‐Omar, Y. (2026) · Perfusion · doi:10.1177/02676591261488628
Surgery for infective endocarditis: Staphylococcus aureus versus other microbiological etiologies
Nielsen, S. T., Graversen, P. L., Hadji-Turdeghal, K., Møller, J. E., Bruun, N. E., Jensen, A. D., Petersen, J. K., Povlsen, J. A., Moser, C., Smerup, M., et al. (2026) · JTCVS Open · doi:10.1016/j.xjon.2026.102109
Bhattarai, N., Stevens, R. W., Baddour, L. M., DeSimone, D. C., Chesdachai, S., Hindy, J.-R., Dierkhising, R., & Ilges, D. (2026) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofag568
Shil, R., & Das, S. (2026) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2026/v38i107877
Nguyễn, T. T. L., & Nguyễn, T. M. L. (2026) · Tạp chí Tim Mạch Học Việt Nam · doi:10.58354/jvc.122.2026.1332
Kaur, N. D., Kumar, R., Vishwanath, V. M., & Gourav, K. P. (2026) · World Journal for Pediatric and Congenital Heart Surgery · doi:10.1177/21501351261472488
Mitral valve repair for infective endocarditis: surgical technique and long-term results
Khramchenkov, A. G., Titov, D. A., Сачков, А. С., Ивановна, Б. С., Соркомов, М. Н., & Муратович, М. Р. (2026) · Russian Journal of Cardiology and Cardiovascular Surgery · doi:10.17116/kardio20261905169
The impact of intraoperative hemoadsorption during cardiac surgery for infective endocarditis
Serradj, A., Saiydoun, G., Radu, C., Bergoend, É., Fiore, A., Huguet, R., Lim, P., Moini, C., & Folliguet, T. A. (2026) · Intensive Care Medicine Experimental · doi:10.1186/s40635-026-00988-0
Nishino, T., Mase, H., Kim, C., Sugita, S., Kondo, Y., & Ishikawa, M. (2026) · JMIR Perioperative Medicine · doi:10.2196/91315
ENDOCARDITE INFECCIOSA: CRITÉRIOS DIAGNÓSTICOS E INDICAÇÃO DE TRATAMENTO CIRÚRGICO
Pinto, P. C., Friedrich, M., da Costa, L. H., Nascimento, J. R. R. D., Júnior, L. H. D. F., & Coutinho, R. V. D. S. (2026) · Artefactum · doi:10.23900/artefactum.v25i12.226
Musaev, O. G., Lebedeva, K. B., Леонардович, Б. Н., Амирбеков, М. М., Tyurin, M. Y., & Vechorko, V. I. (2026) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2026-15-5-151-165
Metadata
- Authors
- Kang, D.-H., Kim, Y.-J., Kim, S.-H., Sun, B. J., Kim, D.-H., Yun, S.-C., Song, J.-M., Choo, S. J., Chung, C.-H., Song, J.-K., Lee, J.-W., & Sohn, D.-W.
- Affiliations
- Asan Medical Center (KR)
- Seoul National University Hospital (KR)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-06-28
- Volume
- 366
- Issue
- 26
- Pages
- 2466-2473
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2166377714
- Semantic Scholar
- 461d182c777391ac49d213c8ce8c7fc5a28624da
- Cited by
- 902
- References
- 22
- Citations by year
- 2026: 42 · 2025: 57 · 2024: 73 · 2023: 59 · 2022: 62 · 2021: 75 · 2020: 74 · 2019: 78 · 2018: 58 · 2017: 52 · 2016: 58 · 2015: 64 · 2014: 61 · 2013: 65 · 2012: 23
- FWCI
- 51.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- infective endocarditis, early surgical intervention, valve surgery, systemic embolism, left-sided endocarditis, in-hospital mortality, embolic events, antibiotic therapy
- MeSH terms
- Adult, Embolism, Endocarditis, Bacterial, Female, Humans, Male, Middle Aged, Postoperative Complications, Prospective Studies, Time Factors, Hospital Mortality, Kaplan-Meier Estimate, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.